APOE U19-related publications

CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly The immune system substantially influences age-related cognitive decline and Alzheimer’s disease (AD) progression, affected by genetic and...

ApoE and α-synuclein

A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides. Gallardo, G., Schlüter, O. M., & Südhof, T. C. (2008).  Nature neuroscience, 11(3), 301308. α-Synuclein Interacts with Lipoproteins in Plasma. Emamzadeh, F. N., &...

ApoE and Other Diseases

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Peila, R., Rodriguez, B. L., Launer, L. J., & Honolulu-Asia Aging Study (2002).  Diabetes, 51(4), 12561262. The association between apolipoprotein E gene...

ApoE and Other Neurodegenerative Disorders

Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Robinson, J. L., Lee, E. B., Xie, S. X., Rennert, L., Suh, E., Bredenberg, C., Caswell, C., Van Deerlin, V. M., Yan, N., Yousef, A., Hurtig, H. I., Siderowf, A.,...